CD8+ T cell loss induces autoinflammation in inborn errors of cell death
Systemic autoinflammatory diseases (SAID) with inborn errors of cell death (IECD) are caused by overactivation of programmed cell death (PCD). However, the pathogenesis by which PCD leads to autoinflammation remains unclear. Here, we identified IECD patients carrying compound heterozygous RIPK1 variants K377E/R390G with autoinflammatory manifestations. Mechanistically, K377E and R390G mutations suppress NF-κB signaling and activate RIPK1 to promote cell death. CD8<sup>+</sup> T cells of the patients displayed overactivated RIPK1 and excessive cell death, leading to an elevated CD4/CD8 ratio, which could also be detected in patients with cleavage-resistant mutation of RIPK1 or SHARPIN deficiency. We show that the increased cell death of CD8<sup>+</sup> T cells promotes TNF and IFN-γ secretion to activate monocytes/macrophages, which triggers overproduction of proinflammatory cytokines. In addition, disruption of the communication between T cells and monocytes/macrophages through pharmacologic blockade of TNF and IFN attenuates proinflammatory cytokine production in macrophages and relieves all the symptoms in patients. This study further clarifies the mechanism for a group of IECD with SAID. Increased CD4/CD8 ratio and augmented RIPK1 activation in T cells provide potentially additional criteria for diagnosis of RIPK1-dependent IECD and a combination of TNF/JAK inhibitor could be an effective therapy for the diagnosed patients.
Authors
- Ivona Aksentijevich (ORCID: https://orcid.org/0000-0002-6564-7214)
- Jianming Lai (ORCID: https://orcid.org/0000-0002-9309-9542)
- Taijie Jin
- Min Wen
- Junying Yuan
- Wenjie Zheng
- Ming Li
- Sergio D. Rosenzweig
- Xiaomin Yu
- Gaixiu Su
- Li Guo
- Feifei Wu
- Qiuye Zhang
- Hye Sun Kuehn
- Jia Zhu
- Xu Han
- Jialin Dai
- Yingjie Xu
- Min Kang
- Tong Yue
- Shihao Wang
- Dan Zhang
- Pui Y. Lee
- Qing Zhou
- Jun Wang
- Ranran Zhang
- Chenlu Liu
- Jiahui Zhang
- Jun Yang
Institutions
- Qingdao University (CN)
- Boston Children's Hospital (US)
- National Institutes of Health (US)
- Harvard University (US)
- Chinese Academy of Sciences (CN)
- Wenzhou Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- National Human Genome Research Institute (US)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
- Shanghai Institute of Organic Chemistry (CN)
- Children's Hospital of Zhejiang University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Beijing Children’s Hospital (CN)
- Shenzhen Children's Hospital (CN)
- National Institutes of Health Clinical Center (US)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1038/s41467-026-70317-2
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00